Propanc Biopharma Statistics
Total Valuation
PPCB has a market cap or net worth of $18.95 million. The enterprise value is $19.64 million.
Important Dates
The last earnings date was Tuesday, September 30, 2025.
| Earnings Date | Sep 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PPCB has 12.81 million shares outstanding.
| Current Share Class | 12.81M |
| Shares Outstanding | 12.81M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +168.42% |
| Owned by Insiders (%) | 65.26% |
| Owned by Institutions (%) | 3.90% |
| Float | 3.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.16 |
| P/TBV Ratio | 1.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.50, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.50 |
| Quick Ratio | 0.00 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -101.60 |
Financial Efficiency
Return on equity (ROE) is -1,163.67% and return on invested capital (ROIC) is -559.26%.
| Return on Equity (ROE) | -1,163.67% |
| Return on Assets (ROA) | -363.36% |
| Return on Invested Capital (ROIC) | -559.26% |
| Return on Capital Employed (ROCE) | -407.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$29.46M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.01% in the last 52 weeks. The beta is 19,964.30, so PPCB's price volatility has been higher than the market average.
| Beta (5Y) | 19,964.30 |
| 52-Week Price Change | -94.01% |
| 50-Day Moving Average | 2.45 |
| 200-Day Moving Average | 8.29 |
| Relative Strength Index (RSI) | 37.14 |
| Average Volume (20 Days) | 342,373 |
Short Selling Information
The latest short interest is 212,160, so 1.66% of the outstanding shares have been sold short.
| Short Interest | 212,160 |
| Short Previous Month | 171,527 |
| Short % of Shares Out | 1.66% |
| Short % of Float | 6.65% |
| Short Ratio (days to cover) | 0.51 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -57.28M |
| Pretax Income | -58.92M |
| Net Income | -58.92M |
| EBITDA | -57.28M |
| EBIT | -57.28M |
| Earnings Per Share (EPS) | -$14.85 |
Full Income Statement Balance Sheet
The company has $12,088 in cash and $1.73 million in debt, giving a net cash position of -$1.71 million or -$0.13 per share.
| Cash & Cash Equivalents | 12,088 |
| Total Debt | 1.73M |
| Net Cash | -1.71M |
| Net Cash Per Share | -$0.13 |
| Equity (Book Value) | 13.91M |
| Book Value Per Share | 1.20 |
| Working Capital | 2.77M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -405,168 |
| Capital Expenditures | n/a |
| Free Cash Flow | -405,168 |
| FCF Per Share | -$0.03 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PPCB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -328.64% |
| FCF Yield | -2.26% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 29, 2025. It was a reverse split with a ratio of 1:59,880.24.
| Last Split Date | Jan 29, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:59,880.24 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |